Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-14

FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a generic formulation of chlordiazepoxide hydrochloride and clidinium bromide from Aurobindo Pharma Limited under an Original Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlordiazepoxide hydrochloride and clidinium bromide (Chlordiazepoxide hydrochloride and clidinium bromide)

Snippet

ORIG AP for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE (CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE)